MedPath
HSA Approval

PREGABALIN ORION HARD CAPSULE 150MG

SIN17037P

PREGABALIN ORION HARD CAPSULE 150MG

PREGABALIN ORION HARD CAPSULE 150MG

July 1, 2024

ORION PHARMA (SG) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantORION PHARMA (SG) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N02BF02

Manufacturer Information

ORION PHARMA (SG) PTE. LTD.

Pharmathen International S.A

Pharmathen S.A. (Primary and Secondary packager)

Active Ingredients

Pregabalin

150.00mg

Pregabalin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PREGABALIN ORION HARD CAPSULE 150MG - HSA Approval | MedPath